MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 67 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,587 | -63.9% | 27,590 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $9,932 | -23.4% | 27,590 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,967 | -13.8% | 27,590 | -8.3% | 0.00% | 0.0% |
| Q4 2022 | $15,045 | -20.8% | 30,090 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $19,000 | -20.8% | 30,090 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $24,000 | 0.0% | 30,090 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $24,000 | -7.7% | 30,090 | +16.1% | 0.00% | 0.0% |
| Q4 2021 | $26,000 | -13.3% | 25,925 | +12.1% | 0.00% | 0.0% |
| Q3 2021 | $30,000 | +87.5% | 23,125 | +12.1% | 0.00% | +100.0% |
| Q2 2021 | $16,000 | -27.3% | 20,625 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $22,000 | -21.4% | 20,625 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $28,000 | +75.0% | 20,625 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $16,000 | 0.0% | 20,625 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $16,000 | +33.3% | 20,625 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -74.5% | 20,625 | 0.0% | 0.00% | -66.7% |
| Q4 2019 | $47,000 | +261.5% | 20,625 | 0.0% | 0.01% | +200.0% |
| Q3 2019 | $13,000 | – | 20,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
| Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
| CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
| Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
| Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
| Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
| J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
| Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
| IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |